[1]张琼,黄雄杰,裴晓华,等.基于“毒损肺络”理论辨治重症新型冠状病毒肺炎[J].西部中医药,2022,35(04):9-12.[doi:10.12174/j.issn.2096-9600.2022.04.03]
　ZHANG Qiong,HUANG Xiongjie,PEI Xiaohua,et al.Differentiation and Treatment of Severe COVID-19 Based on "Toxin Damaging Pulmonary Collateral" Theory[J].Western Journal of Traditional Chinese Medicine,2022,35(04):9-12.[doi:10.12174/j.issn.2096-9600.2022.04.03]
点击复制

基于“毒损肺络”理论辨治重症新型冠状病毒肺炎
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年04期
页码:
9-12
栏目:
出版日期:
2022-04-15

文章信息/Info

Title:
Differentiation and Treatment of Severe COVID-19 Based on "Toxin Damaging Pulmonary Collateral" Theory
作者:
张琼1, 黄雄杰1, 裴晓华2, 樊英怡3
1.北京中医药大学，北京 100029
2.北京中医药大学房山医院
3.北京中医药大学第三附属医院
Author(s):
ZHANG Qiong1, HUANG Xiongjie1, PEI Xiaohua2, FAN Yingyi3
1.Beijing University of Chinese Medicine, Beijing 100029, China
2.Fangshan Hospital of Beijing University of Chinese Medicine
3.The Third Affiliated Hospital of Beijing University of Chinese Medicine
关键词:
新型冠状病毒肺炎; 清肺排毒汤; 毒损肺络
Keywords:
COVID-19; lung-clearing toxin-removing decoction; toxin damaging pulmonary collateral
分类号:
R563.1
DOI:
10.12174/j.issn.2096-9600.2022.04.03
文献标志码:
A
摘要:
基于肺之阳络、阴络、气络、血络的生理功能，结合毒邪致病的特点，认为新型冠状病毒肺炎（Corona Virus Disease 2019，COVID-19）（简称新冠肺炎）发病急骤，易瘀、易滞、易传；重症阶段，湿毒、热毒、痰毒、瘀毒相互依附胶着造成的主客交浑、耗气动血是“毒损肺络”病机的关键。应遵循解毒通络、给邪以出路的治疗原则，具体为解热毒以通肺络、化瘀毒以通肺络、祛痰毒以通肺络，并基于“毒损肺络”理论对清肺排毒汤进行组方分析，为络病学防治急性传染病提供新的思路和理论依据。
Abstract:
On the foundation of physiological function of Yang collateral, Yin collateral, Qi collateral and blood collateral of the lung, combined with the pathogenic characteristics of toxin, COVID-19 has the features of attacking rapidly, easily stagnating, blocking and transmitting; at the critical stage, muddy between host and guest, Qi consumption and blood disorder caused by attachment and adhesion of damp toxin, heat toxin, phlegm toxin and stasis toxin mutually are the key of the pathogenesis of "toxin damaging pulmonary collateral". Therapeutic principles of "detoxifying and dredging collateral, finding outlet for the pathogenic factors" should be followed, specifically eliminating heat toxin to free pulmonary collateral, resolving stagnation toxin to dredge pulmonary collateral and removing phlegm toxin to clear pulmonary collateral, and lung-clearing toxin-removing decoction was analyzed based on "toxin damaging pulmonary collateral" theory, and it could provide new thinking and theoretical evidence for the prevention and treatment of acute infectious disease by the study of collateral.

相似文献/References:

[1]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
　SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(04):3.
[2]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
　DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(04):5.
[3]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
　PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(04):7.
[4]杨海侠,张银萍△,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药,2020,33(S1):13.
[5]丁潇,邹忆怀△,辛大永,等.北京顺义地区新型冠状病毒肺炎的中医临床证候与CT表现[J].西部中医药,2020,33(S1):16.
　DING Xiao,ZOU Yihuai,XIN Dayong,et al.TCM Clinical Syndromes and CT Manifestations of COVID-19 in Shunyi District of Beijing[J].Western Journal of Traditional Chinese Medicine,2020,33(04):16.
[6]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
　SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(04):18.
[7]闫向勇,李 俊,燕忠生△.武汉地区新型冠状病毒肺炎中医证候及病机特点[J].西部中医药,2020,33(S1):20.
　YAN Xiangyong,LI Jun,YAN Zhongsheng.On the Characteristics of TCM Patterns and the Pathogenesis of COVID-19 in Wuhan Region[J].Western Journal of Traditional Chinese Medicine,2020,33(04):20.
[8]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
　and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(04):24.[doi:10.1056/NEJMoa-2001017]
[9]朱玉,黎玉婷,姚德蛟△.从中西医不同角度分析麻杏石甘汤治疗新型冠状病毒肺炎的作用[J].西部中医药,2020,33(S1):26.
　of Traditional Chinese Medicine and Western Medicine.The Functions of Maxing Shigan Tang in the Treatment for COVID-19 from the Angles[J].Western Journal of Traditional Chinese Medicine,2020,33(04):26.
[10]张燕琴,孔维维,禇晓霞,等.甘肃省第一批援鄂医疗队新型冠状病毒肺炎隔离病房护理管理体会[J].西部中医药,2020,33(S1):22.[doi:org/10.13609/j.cnki.1000-]
　ZHANG Yanqin,KONG Weiwei,CHU Xiaoxia,et al.The First Batch of Gansu-Based Medical Teams Experience of Nursing Management on the COVID-19 Isolation Ward in Hubei[J].Western Journal of Traditional Chinese Medicine,2020,33(04):22.[doi:org/10.13609/j.cnki.1000-]
[11]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
　LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(04):1.
[12]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(04):18.[doi:10.12174/j.issn.1004-6852.2020.04.06]
　LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatmentto COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(04):18.[doi:10.12174/j.issn.1004-6852.2020.04.06]

备注/Memo

备注/Memo:
张琼（1994—），女，在读硕士研究生。研究方向：乳腺疾病的中医药防治。
更新日期/Last Update: 2022-06-24